Auriga Maintains 'Buy' on Herbalife (HLF); Takeaways From Analyst Meeting
Tweet
Share
E-mail
Get Alerts HLF Hot Sheet
Price: $11.99 -2.76%
Rating Summary:
11 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
11 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Auriga maintains a 'Buy' on Herbalife (NYSE: HLF) price target of $68.00.
Analyst, Gary Albanese, said, "Herbalife management, including Pres. Des Walsh, CFO John DeSimone and IR Director Amy Greene, met this morning with its sell-side equity coverage in New York to provide an update since the end of the quarter. Michael Johnson, Herbalife Chairman and CEO, was unavailable to make the trip due to a recent sports-related injury but remains in contact with other management members. The update revolved around the involvement of hedge fund manager David Einhorn, who asked a question on the recent conference call and whose contribution likely led to the 24% decline in the share price since the earnings release. Background with Einhorn. Aside from the questions that Mr. Einhorn asked on the conference call, his interest in Herbalife has been building. One of his associates participated in the company's analyst day, but the questions were thought to non-confrontational, regulatory type questions. In addition, there is another person, likely working as a consultant, which has been contacting ex-customers and ex-distributors to get their thoughts on the company. Aside from that contact, including the conference call questions, there has not been any further contact with David Einhorn or Greenlight Capital."
For an analyst ratings summary and ratings history on Herbalife click here. For more ratings news on Herbalife click here.
Shares of Herbalife closed at $45.55 yesterday.
Analyst, Gary Albanese, said, "Herbalife management, including Pres. Des Walsh, CFO John DeSimone and IR Director Amy Greene, met this morning with its sell-side equity coverage in New York to provide an update since the end of the quarter. Michael Johnson, Herbalife Chairman and CEO, was unavailable to make the trip due to a recent sports-related injury but remains in contact with other management members. The update revolved around the involvement of hedge fund manager David Einhorn, who asked a question on the recent conference call and whose contribution likely led to the 24% decline in the share price since the earnings release. Background with Einhorn. Aside from the questions that Mr. Einhorn asked on the conference call, his interest in Herbalife has been building. One of his associates participated in the company's analyst day, but the questions were thought to non-confrontational, regulatory type questions. In addition, there is another person, likely working as a consultant, which has been contacting ex-customers and ex-distributors to get their thoughts on the company. Aside from that contact, including the conference call questions, there has not been any further contact with David Einhorn or Greenlight Capital."
For an analyst ratings summary and ratings history on Herbalife click here. For more ratings news on Herbalife click here.
Shares of Herbalife closed at $45.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- XP Inc. (XP) Tops Q2 EPS by 8c
- XP Inc eyes US banking license as next business step
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Greenlight Capital, David Einhorn, Hedge Funds, Auriga, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
